Prostaglandin F2alpha: Difference between revisions

Prostaglandin F2alpha
	File:Dinoprost.svg
INN
Drug class
Routes of administration	Intramuscular, Intrauterine
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number	551-11-1
PubChem	5280360
DrugBank	DB01160
ChemSpider	4445530
KEGG	D00074

Latest revision as of 03:01, 11 December 2024

Overview of Prostaglandin F2alpha

Prostaglandin F2α (PGF2α) is a naturally occurring prostaglandin used in medicine to induce labor and as a treatment for postpartum hemorrhage. It is also used in veterinary medicine to synchronize estrus in livestock.

Biological Role[edit]

Prostaglandin F2α is a member of the prostaglandin family, which are lipid compounds derived from fatty acids. PGF2α plays a crucial role in the reproductive system, particularly in the regulation of the estrous cycle and the induction of parturition. It is synthesized in the endometrium and acts on the corpus luteum to induce luteolysis, leading to a decrease in progesterone production and the initiation of a new estrous cycle.

Medical Uses[edit]

In human medicine, PGF2α is used to induce labor and control postpartum hemorrhage due to its ability to stimulate uterine contractions. It is administered via intramuscular or intrauterine routes. PGF2α is also used in the management of glaucoma as it can reduce intraocular pressure.

In veterinary medicine, PGF2α is used to synchronize estrus in cattle, swine, and other livestock. This is achieved by inducing luteolysis, which allows for controlled breeding programs.

Mechanism of Action[edit]

Prostaglandin F2α exerts its effects by binding to specific prostaglandin receptors on the surface of target cells. This binding activates intracellular signaling pathways that lead to increased intracellular calcium levels, resulting in muscle contraction. In the uterus, this causes the myometrium to contract, facilitating labor or expulsion of the placenta.

Side Effects[edit]

The use of PGF2α can lead to side effects such as nausea, vomiting, diarrhea, and fever. In some cases, it may cause bronchospasm, particularly in patients with a history of asthma.

Also see[edit]

References[edit]

Smith, W. L., & Marnett, L. J. (1991). Prostaglandin endoperoxide synthase: structure and catalysis. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1083(1), 1-17.
Fortier, M. A., Guilbault, L. A., & Grasso, F. (1988). Specific properties of epithelial and stromal cells from the endometrium of cows. Journal of Reproduction and Fertility, 83(1), 239-248.

Template:Reproductive system drugs Template:Veterinary drugs

@@ Line 1: / Line 1: @@
-== Prostaglandin F2alpha ==
+{{Short description|Overview of Prostaglandin F2alpha}}
+{{Infobox drug
+| name = Prostaglandin F2α
+| image = Dinoprost.svg
+| caption = Chemical structure of Dinoprost
+| image2 = Lutalyse.jpg
+| caption2 = Lutalyse, a veterinary product containing Prostaglandin F2α
+| tradename = Lutalyse, Prostin F2 Alpha
+| pregnancy_category =
+| legal_status =
+| routes_of_administration = Intramuscular, Intrauterine
+| bioavailability =
+| protein_bound =
+| metabolism =
+| elimination_half-life =
+| excretion =
+| CAS_number = 551-11-1
+| ATC_prefix = G02
+| ATC_suffix = AD01
+| PubChem = 5280360
+| DrugBank = DB01160
+| ChemSpiderID = 4445530
+| UNII = 5B5JX6523E
+| KEGG = D00074
+| ChEBI = 15551
+| ChEMBL = 1201320
+}}
-Prostaglandin F2alpha (PGF2α) is a naturally occurring prostaglandin that plays a crucial role in various physiological processes in the human body. It belongs to the family of lipid compounds known as prostaglandins, which are derived from arachidonic acid.
+'''Prostaglandin F2α''' (PGF2α) is a naturally occurring prostaglandin used in medicine to induce labor and as a treatment for postpartum hemorrhage. It is also used in veterinary medicine to synchronize estrus in livestock.
-=== Structure and Biosynthesis ===
+==Biological Role==
+Prostaglandin F2α is a member of the [[prostaglandin]] family, which are lipid compounds derived from fatty acids. PGF2α plays a crucial role in the reproductive system, particularly in the regulation of the [[estrous cycle]] and the induction of [[parturition]]. It is synthesized in the [[endometrium]] and acts on the [[corpus luteum]] to induce luteolysis, leading to a decrease in [[progesterone]] production and the initiation of a new estrous cycle.
-PGF2α is a 20-carbon fatty acid with a cyclopentane ring and two side chains. It is synthesized from arachidonic acid through a series of enzymatic reactions. The key enzyme involved in the biosynthesis of PGF2α is prostaglandin-endoperoxide synthase (also known as cyclooxygenase or COX). COX catalyzes the conversion of arachidonic acid into prostaglandin H2 (PGH2), which is further metabolized by specific enzymes to produce PGF2α.
+==Medical Uses==
+In human medicine, PGF2α is used to induce labor and control postpartum hemorrhage due to its ability to stimulate uterine contractions. It is administered via intramuscular or intrauterine routes. PGF2α is also used in the management of [[glaucoma]] as it can reduce intraocular pressure.
-=== Biological Functions ===
+In veterinary medicine, PGF2α is used to synchronize estrus in cattle, swine, and other livestock. This is achieved by inducing luteolysis, which allows for controlled breeding programs.
-PGF2α has diverse biological functions and acts as a potent mediator in various physiological and pathological processes. Some of its key functions include:
+==Mechanism of Action==
+Prostaglandin F2α exerts its effects by binding to specific [[prostaglandin receptors]] on the surface of target cells. This binding activates intracellular signaling pathways that lead to increased intracellular calcium levels, resulting in muscle contraction. In the uterus, this causes the myometrium to contract, facilitating labor or expulsion of the placenta.
-. **Uterine Contraction**: PGF2α is a major mediator of uterine contraction during labor and menstruation. It acts on the smooth muscle cells of the uterus, causing them to contract and facilitate the expulsion of the fetus during childbirth or the shedding of the uterine lining during menstruation.
+==Side Effects==
+The use of PGF2α can lead to side effects such as nausea, vomiting, diarrhea, and fever. In some cases, it may cause bronchospasm, particularly in patients with a history of [[asthma]].
-. **Ovulation**: PGF2α is involved in the process of ovulation, where it helps in the rupture of the ovarian follicle and the release of the mature egg. It acts on the smooth muscle cells surrounding the follicle, causing vasoconstriction and subsequent rupture.
+==Also see==
+* [[Prostaglandin]]
+* [[Estrous cycle]]
+* [[Luteolysis]]
+* [[Parturition]]
+* [[Glaucoma]]
-. **Inflammation**: PGF2α is a potent pro-inflammatory mediator. It is involved in the recruitment of immune cells to sites of inflammation and promotes the release of other inflammatory mediators, such as cytokines and chemokines.
+==References==
+* Smith, W. L., & Marnett, L. J. (1991). Prostaglandin endoperoxide synthase: structure and catalysis. ''Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism'', 1083(1), 1-17.
+* Fortier, M. A., Guilbault, L. A., & Grasso, F. (1988). Specific properties of epithelial and stromal cells from the endometrium of cows. ''Journal of Reproduction and Fertility'', 83(1), 239-248.
-. **Vasoconstriction**: PGF2α induces vasoconstriction, leading to the narrowing of blood vessels. This effect is particularly important in regulating blood flow to various organs and tissues.
+{{Reproductive system drugs}}
+{{Veterinary drugs}}
-. **Bronchoconstriction**: PGF2α plays a role in bronchoconstriction, which is the narrowing of the airways in the lungs. This effect can contribute to respiratory symptoms in conditions such as asthma.
+[[Category:Prostaglandins]]
+[[Category:Reproductive system drugs]]
-=== Clinical Applications ===
+[[Category:Veterinary drugs]]
-Due to its diverse biological functions, PGF2α has several clinical applications. Some of the notable applications include:
-. **Induction of Labor**: PGF2α analogs, such as dinoprostone, are used to induce labor in pregnant women. These analogs mimic the effects of endogenous PGF2α, leading to uterine contractions and initiation of labor.
-. **Treatment of Glaucoma**: PGF2α analogs, such as latanoprost, are used in the treatment of glaucoma. These analogs help in reducing intraocular pressure by increasing the outflow of aqueous humor from the eye.
-. **Control of Postpartum Hemorrhage**: PGF2α analogs, such as carboprost tromethamine, are used to control postpartum hemorrhage, which is excessive bleeding after childbirth. These analogs help in contracting the uterus and reducing bleeding.
-=== References ===
-. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-182. doi:10.1146/annurev.biochem.69.1.145.
-. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993;90(24):11693-11697. doi:10.1073/pnas.90.24.11693.
-. Woodward DF, Krauss AH, Chen J, et al. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45 Suppl 4:S337-S345. doi:10.1016/s0039-6257(01)00271-2.
-. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization; 2012.<br>{{stub}}
-{{dictionary-stub1}}